Baseline characteristics
A total of 109 screened subjects, 40 participants were eligible and enrolled in the study. Ten participants were randomly assigned into 5, 15, 30, and 50 mg/kg dose group respectively, of which 8 received JMB2002 and 2 received placebo (Fig. 
Scheme of participant selection for the clinical trialThe baseline characteristics and demographic information of 40 participants are listed in (Table 
Participants characteristicsThe percentage was calculated based on the number of subjects enrolled in each dose group